John MacMahon – CEO, co-founder
Expert in early-stage medical device and first-in-man clinical trials. Former founder and CEO of Kerberos Proximal Solutions (sold to FHT), COO for Maya Medical (sold to COV) and General Manager for Claret (sold to BSX).Â
Ben Wang – Chief Science Officer
PhD CEO of Chimera Bioengineering and co-founder of Cytokind, specializing in intersectional scientific and engineering in immunology. At Chimera, Ben is focused on controlling immune toxicity and cytokine release syndromes endemic in CAR-T therapy.
Greg Casciaro – Chairman
Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry. Former President & CEO of Cardiac Dimensions Inc., Access Closure Inc., Orquest, Inc., and General Surgical Innovations.
Craig Ullman – General Manager
Senior operations executive focusing on technology startups with successful exits. He is also a named inventor on numerous foundational patents, including 2 of the first fifty on the Word Wide Web, and winner of Digital Luminary Award
Carmen Castilla – Director of Clinical Phototherapy
MD Medical Dermatologist at New York Dermatology Group. Dr. Castilla sees the skin’s critical interplay with the systemic immune system as an important and non-invasive pathway to systemic immunomodulation.
Iva Kaufman – Advocacy & Outreach
Iva Kaufman applies an interdisciplinary approach to business and philanthropy, social finance, funding, in both commercial and not-for-profit management.Â